PLOS ONE: Mutations in Specific Structural Regions of Immunoglobulin Light Chains Are Associated with Free Light Chain Levels in Patients with AL Amyloidosis
Identification of two principal amyloid-driving segments in variable domains of Ig light chains in systemic light-chain amyloidosis - Journal of Biological Chemistry
Treatment of Immunoglobulin Light Chain Amyloidosis - Mayo Clinic Proceedings
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis | NEJM
Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021 | Blood Cancer Journal
Amyloidosis (Light Chain): Organs Affected, Symptoms, Treatments
Systemic immunoglobulin light chain amyloidosis | Nature Reviews Disease Primers
Cardiac amyloidosis: An update on diagnosis and treatment | Cleveland Clinic Journal of Medicine
Systemic immunoglobulin light chain amyloidosis | Nature Reviews Disease Primers
AL Amyloidosis: Current Chemotherapy and Immune Therapy Treatment Strategies: JACC: CardioOncology State-of-the-Art Review | JACC: CardioOncology
What do I need to know about immunoglobulin light chain (AL) amyloidosis? - ScienceDirect
Genetic pathogenesis of immunoglobulin light chain amyloidosis: basic characteristics and clinical applications | Experimental Hematology & Oncology | Full Text
Amyloid Goiter as the First Recognizable Manifestation of Immunoglobulin Light Chain Amyloidosis - AACE Clinical Case Reports
SciELO - Brasil - Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies Serum free light chain assays not total light chain
Amyloidosis | Saint Luke's Health System
Light chain amyloidosis pathology. Clonal expansion of plasma cells... | Download Scientific Diagram
Update on treatment of light chain amyloidosis | Haematologica
Light-Chain (AL) Amyloidosis: Diagnosis and Treatment | American Society of Nephrology
Systemic immunoglobulin light chain amyloidosis | Nature Reviews Disease Primers
Hemato | Free Full-Text | Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis
Understanding Mesangial Pathobiology in AL-Amyloidosis and Monoclonal Ig Light Chain Deposition Disease - Kidney International Reports
Understanding Mesangial Pathobiology in AL-Amyloidosis and Monoclonal Ig Light Chain Deposition Disease - Kidney International Reports
Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis - ScienceDirect
